| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 135,098 | 137,546 | 128,974 | 132,303 | | Cost of Revenue | 31,985 | 36,909 | 32,806 | 34,730 | | | Gross Profit | 103,113 | 100,637 | 96,168 | 97,573 | | | Operating Expenses | | Research Development | 7,864 | 8,886 | 9,087 | 11,444 | | Selling General and Administrative | 75,830 | 76,463 | 74,948 | 74,815 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,668 | 1,643 | 1,633 | 1,874 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,751 | 13,645 | 10,500 | 9,440 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (917) | 1,461 | (84) | (9,398) | | Earnings Before Interest And Taxes | (1,551) | 15,106 | 10,416 | 42 | | Interest Expense | (11,948) | 5,831 | 6,117 | 6,508 | | Income Before Tax | 10,397 | 9,275 | 4,299 | (6,466) | | Income Tax Expense | 4,209 | 3,331 | 1,420 | (5,749) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,188 | 5,944 | 2,879 | (717) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,188 | 5,944 | 2,879 | (717) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,188 | $5,944 | $2,879 | ($717) |
|
0.51% Nasdaq 
Income Statement
